welcome Welcome

“May all be happy, may all be healed, may all be at peace and may no one ever suffer."


Novartis (Bangladesh) Ltd.

N/A, N/A
...
Novartis (Bangladesh) Ltd.
Loading...

Trileptal 60mg / ml

Size: 100 ml bottle Price: 1072.00
Oral Suspension Oral Suspension
Oxcarbazepine
Adjunct anti-epileptic drugs
0.00 (0)



Alternate Strengths


Generic for Diseases

Generic Indications
  • Cerebral palsy
  • Epilepsy
  • Generalized tonic-clonic seizures
  • Neuralgia
  • Partial seizures
  • Seizures
  • Trigeminal neuralgia

Generic Description

The pharmacological activity of Oxcarbazepine is primarily exerted through the metabolite derivative (the monohydroxy derivative, MHD) of Oxcarbazepine. The mechanism of action of Oxcarbazepine and MHD is thought to be mainly based on blockade of voltage-sensitive sodium channels, thus resulting in stabilization of hyper excited neural membranes, inhibition of repetitive neuronal firing and diminishment of propagation of synaptic impulses.


Component

Drug Indication

Oxcarbazepine is indicated for:

Adults: Monotherapy or adjunctive therapy in the treatment of partial seizures

Pediatrics:

  • Monotherapy in the treatment of partial seizures in children 4-16 years
  • Adjunctive therapy in the treatment of partial seizures in children 2–16 years

Dosage Administration

Adults: initiate with a dose of 600 mg/day, given twice-a-day

  • Adjunctive Therapy: Maximum increment of 600 mg/day at approximately weekly intervals. The recommended daily dose is 1200 mg/day
  • Conversion to Monotherapy: withdrawal concomitant over 3 to 6 weeks;reach maximum dose of Oxcarbazepine in 2 to 4 weeks with increments of 600 mg/day at weekly intervals to a recommended daily dose of 2400 mg/day
  • Initiation of Monotherapy: Increments of 300 mg/day every third day to a dose of 1200 mg/day.
  • Creatinine Clearance <30 mL/min: Initiate at one half the usual starting dose and increase slowly

Pediatrics: initiation with 8 to 10 mg/kg/day, given twice-a-day. For patients aged 2 to <4 years and under 20 kg, a starting dose of 16 to 20 mg/kg/day may be considered. Recommended daily dose is dependent upon patient weight.

  • Adjunctive Patients (Aged 2–16 Years): For patients aged 4 to 16 years, target maintenance dose should be achieved over 2 weeks. For patients aged 2 to <4 years, maximum maintenance dose should be achieved over 2 to 4 weeks and should not to exceed 60 mg/kg/day
  • Conversion to Monotherapy for Patients (Aged 4-16 Years): Maximum increment of 10 mg/kg/day at weekly intervals, concomitant antiepileptic drugs can be completely withdrawn over 3 to 6 weeks
  • Initiation of Monotherapy for Patients (Aged 4–16 Years): Increments of 5 mg/kg/day every third day

Contraindication

It is contraindicated to patients with hypersensitivity to the active substance or to any of the excipients.


Side Effect

The most commonly reported adverse reactions are somnolence, headache, dizziness, diplopia, nausea; vomiting and fatigue. Very rarely clinically significant hyponatraemia can develop during Oxazep use. Class I (immediate) hypersensitivity reactions including rash, pruritus, urticaria, angioedema and reports of anaphylaxis have been received.


Precaution Warning

Alcohol: Caution should be exercised if alcohol is taken in combination with Oxazep therapy, due to a possible additive sedative effect.

Withdrawal: As with all antiepileptic medicinal products, Oxazep should be withdrawn gradually to minimise the potential of increased seizure frequency.

Pregnancy & Lactation

Pregnancy: Data on a limited number of pregnancies indicate that Oxcarbazepine may cause serious birth defects (e.g. cleft palate) when administered during pregnancy. In the newborn child. Bleeding disorders in the newborn caused by antiepileptic agents have been reported. As a precaution, vitamin K1 should be administered as a preventive measure in the last few weeks of pregnancy and to the newborn. Oxcarbazepine and its active metabolite (MHD) cross the placenta. Neonatal and maternal plasma MHD concentrations were similar in one case.

Lactation: Oxcarbazepine and its active metabolite (MHD) are excreted in human breast milk. Therefore, Oxazep should not be used during breast-feeding.





Store

Trileptal 60mg / ml and more Available Brands


...
Exelon 9.5mg / 24...
Rivastigmine Tartrate
Patch
S: 30 , P: 6745.45
...
Exelon 1.5mg
Rivastigmine Tartrate
Capsule
S: 28 , P: 4075.37
...
Afinitor 5mg
Everolimus
Tablet
S: 30 , P: 175049.43
...
Anuva 50mg
Diclofenac Potassium
Tablet
S: 50 , P: 401.00
...
Myfortic 360mg
Mycophenolic acid
Tablet (DR)
S: 120 , P: 18000.00
...
Miacalcic 100IU / ml
Salmon Calcitonin
Injection
S: 5 (1 ml ampoule) , P: 2955.00
...
Votrient 200mg
Pazopanib Hydrochloride
Tablet
S: 30 , P: 18841.77
...
Xolair 150mg / vi...
Omalizumab
SC Injection
S: 150 mg vial , P: 38143.88

Searching Keywords Idea
...

Bangladesh is Number One in Digital Medical Management.
To be happy, beautiful, healthy, wealthy, hale and long-lived stay with DM3S.